middle.news
Moderna raises outlook as melanoma data adds fresh growth potential
10:47pm on Friday 6th of November, 2026 AEDT
•
Biotechnology
Read Story
Moderna raises outlook as melanoma data adds fresh growth potential
10:47pm on Friday 6th of November, 2026 AEDT
Key Points
Third-quarter revenue up 29% to US$1.313 billion
GAAP net income of US$162 million versus a US$200 million loss
2026 revenue growth outlook lifted to 15% to 25%
Year-end cash and investments forecast raised to US$8.1 billion to US$8.3 billion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Moderna (NASDAQ:MRNA)
OPEN ARTICLE